Association of Sijunzi decoction plus chemotherapy with gastrointestinal function and serum markers in patients after gastric carcinoma surgery

Table 1 Patients’ general information

General data	Control group (n = 45)	Research group (n = 54)	χ2/t	P value
Age (years old)	51.47 ± 6.98	52.59 ± 5.88	0.867	0.388
Sex	29/16	30/24	0.805	0.370
Average body mass (kg)	70.91 ± 5.88	68.67 ± 8.25	1.526	0.130
Tumor-nodes-metastasis staging (I/II/III)	9/24/12	11/25/18	0.607	0.738
Histological classification (poorly differentiated adenocarcinoma/tubular adenocarcinoma/signet-ring cell carcinoma)	22/18/5	25/22/7	0.108	0.948
Education level (below senior high school/senior high school or above)	21/24	18/36	1.828	0.176
Family medical history (none/yes)	37/8	40/14	0.943	0.332

Table 2 Incidence of grade III-IV adverse events, n (%)

General data	Control group (n = 45)	Research group (n = 54)	χ2	P value
Gastrointestinal reaction	4 (8.89)	3 (5.56)
Renal function impairment	2 (4.44)	2 (3.70)
Liver function impairment	2 (4.44)	1 (1.85)
Myelosuppression	1 (2.22)	1 (1.85)
Total	9 (20.00)	7 (12.96)	0.897	0.344